Back

Detection of p53 and SV40 Immunostaining in Archived Tumor Nephrectomy Blocks of Children with Nephroblastoma in Kano, Nigeria.

Anyanwu, L.-J. C.; Atanda, A. T.; Mohammed, B. I.; Mba, C. J.

2025-10-28 oncology
10.1101/2025.10.20.25338183 medRxiv
Show abstract

BackgroundImmunohistochemical expression of p53 protein in tumor nephrectomy specimens of patients with nephroblastoma has been associated with an adverse clinical outcome. SV40 is a known tumorigenic virus associated with inflammatory kidney diseases. This study aimed to evaluate the role in clinical outcome of p53 and SV40 immunopositivity in formalin-fixed paraffin-embedded (FFPE) tissue blocks of children with nephroblastoma. Materials and methodsThis was a retrospective study of 24 nephroblastoma patients managed in a tertiary hospital. FFPE tumor tissue blocks from the patients were subjected to immunohistochemical staining for p53 and SV40, and their relationship to clinical outcome was analyzed using the methods of Kaplan - Meier. Statistical significance was set at p [≤]0.05. ResultsThe p53 immunopositivity rate in the study was 20.80% (5/24). None of the patient had a positive SV40 stain. There was a significant association between p53 immunoreactive and gender (p=0.021). The study showed a statistically significant poorer overall survival (OS) for those who showed p53 immunopositivity (p=0.05). ConclusionThe study provides preliminary evidence that p53 immunopositivity is associated with a poor survival. This may thus be used in the detection of patients with a poor prognostic tumor.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 5%
23.7%
2
Gene Reports
13 papers in training set
Top 0.1%
10.6%
3
PeerJ
261 papers in training set
Top 0.5%
6.7%
4
Molecular Biology Reports
19 papers in training set
Top 0.1%
4.5%
5
Scientific Reports
3102 papers in training set
Top 26%
4.5%
50% of probability mass above
6
Heliyon
146 papers in training set
Top 0.3%
3.8%
7
Frontiers in Oncology
95 papers in training set
Top 1%
3.8%
8
Journal of Family Medicine and Primary Care
10 papers in training set
Top 0.2%
2.2%
9
PLOS Neglected Tropical Diseases
378 papers in training set
Top 3%
1.8%
10
Diagnostics
48 papers in training set
Top 0.9%
1.8%
11
Journal of Medical Microbiology
20 papers in training set
Top 0.3%
1.7%
12
BMC Infectious Diseases
118 papers in training set
Top 3%
1.7%
13
Emerging Infectious Diseases
103 papers in training set
Top 2%
1.6%
14
Frontiers in Pharmacology
100 papers in training set
Top 3%
1.4%
15
Cureus
67 papers in training set
Top 3%
1.4%
16
Immunology
29 papers in training set
Top 0.7%
1.0%
17
Biology Methods and Protocols
53 papers in training set
Top 2%
0.9%
18
BMC Research Notes
29 papers in training set
Top 0.3%
0.9%
19
Physiological Reports
35 papers in training set
Top 0.8%
0.9%
20
Brain and Behavior
37 papers in training set
Top 1%
0.8%
21
BMJ Open
554 papers in training set
Top 12%
0.8%
22
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 5%
0.8%
23
JMIR Formative Research
32 papers in training set
Top 2%
0.8%
24
Cancers
200 papers in training set
Top 5%
0.8%
25
Journal of Clinical Medicine
91 papers in training set
Top 6%
0.8%
26
International Journal of Molecular Sciences
453 papers in training set
Top 15%
0.8%
27
Frontiers in Immunology
586 papers in training set
Top 8%
0.8%
28
Journal of Medical Virology
137 papers in training set
Top 5%
0.7%
29
Pathogens
53 papers in training set
Top 2%
0.5%
30
EClinicalMedicine
21 papers in training set
Top 1%
0.5%